Clinical Trial Update: Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating silymarin in chronic hepatitis C patients who failed conventional antiviral therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED